Well, let's see... it's been over 2.5 years since Abbvie walked away from the first potential partnership, the stock is currently valued at less than 1/3 of what is was at the time while the # of outstanding shares has gone up significantly...
"POSSIBLE partnership DISCUSSIONS" aren't worth anything. Apparently, neither is Peregrine.
News 
Market Data 
Discover 
